Pediatric behavioral health company Cognoa has received FDA De Novo classification for its autism spectrum disorder (ASD) software diagnostic aid, Canvas Dx.
The ASD diagnostic tool is designed to help primary care clinicians and pediatricians evaluate and diagnose suspected cases of autism among children. It uses machine learning algorithms to analyze videos of the child’s behavior and responses...
Cognoa, a digital health company developing software tools for children with autism and other behavioral health conditions and their families, signaled today that it will be moving ahead with a De Novo FDA regulatory submission for its digital autism spectrum disorder (ASD) diagnostic.
The tool, which received a Breakthrough Device Designation from the agency in late 2018, is designed to help...
Digital pediatric-behavioral-health company Cognoa announced today the appointment of David Happel as its new CEO. He comes from biopharmaceutical company Chrono Therapeutics, which he led as president, CEO and director, as well as stints at Horizon Therapeutics, Raptom Pharma, Allergen Research Corporation and others.
Brent Vaughan, Cognoa's cofounder and former CEO, will be serving in an...
Digital therapeutics company Dario Health Corp named Yadin Shemmer and Adam Stern to the board of directors.
This isn’t Shemmer’s first go-round in digital health. He served as the CEO of medication management platform Mango Health for two years. He also worked at Everyday Health and cofounded Better2Know.
Stern comes from the world of finance. He is currently the CEO of SternAegis Ventures and...
Cognoa has entered a new partnership with Autism Learning Partners (ALP) that will provide parents with the Cognoa for Child Development app. The tool helps parents log their child’s developmental progress and offers personalized activity suggestions to help support their growth. ALP providers, meanwhile, can review the logs for evidence of autism spectrum disorder to better inform their care and...
Dr. John Halamka, a longtime CIO, executive director and professor tied to Harvard-affiliated Beth Israel Deaconness Medical Center, will be joining the Mayo Clinic on January 1 as the new president of its Mayo Clinic Platform — a digital health project that will deploy “artificial intelligence, the internet of things and an ecosystem of partners,” he wrote in a blog post announcing the move....
The past few days have seen new pivotal trial announcements from two startups eyeing FDA submissions for their digital health offerings.
On Thursday Cognoa unveiled an investigation for its pediatric development monitoring and diagnostic tool. This will be a multi-site, prospective, blinded, active comparator study of the tool, which is intended to support primary care autism diagnoses among...
Cognoa, the maker of a machine learning-based app for tracking children’s health and development, announced today that it has exclusively licensed an AI system designed to improve socialization skills in children with autism spectrum disorder (ASD) from the Stanford University School of Medicine.
Called Superpower Glass, the technology runs on Google Glass and is designed to encourage children’s...
Papa, a startup that schedules companion visits for lonely seniors, has partnered with Humana to support those covered under Medicare Advantage. The Florida-based company trains and provides college-aged assistants to meet and spend time with seniors in their home, and bills itself as a “grandkids on demand” service.
“At Humana, we know if we truly want to impact the health of our Medicare...
In May, a pair of studies were published in the journals Autism Research and the Journal of the American Medical Informatics Association (JAMIA) that evaluated Cognoa’s artificial intelligence-based tool for early identification of autism in children. While both investigations suggest that the tool’s performance significantly exceeded those of other standardized screeners, comparing the two...
